mRNA Vaccines for Infectious Diseases Market

mRNA Vaccines for Infectious Diseases Market aims to provide a comprehensive presentation of the global market for mRNA Vaccines for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines for Infectious Diseases. mRNA Vaccines for Infectious Diseases Market contains market size and forecasts of mRNA Vaccines for Infectious Diseases in global, including the following market information:
Global mRNA Vaccines for Infectious Diseases Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global mRNA Vaccines for Infectious Diseases market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Infectious Disease Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of mRNA Vaccines for Infectious Diseases include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the mRNA Vaccines for Infectious Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines for Infectious Diseases Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, by Type, 2022 (%)
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Vaccines for Infectious Diseases Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Cancer
Global mRNA Vaccines for Infectious Diseases Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Vaccines for Infectious Diseases revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies mRNA Vaccines for Infectious Diseases revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Vaccines for Infectious Diseases, market overview.
Chapter 2: Global mRNA Vaccines for Infectious Diseases market size in revenue.
Chapter 3: Detailed analysis of mRNA Vaccines for Infectious Diseases company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Vaccines for Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.